The rise in oil prices should help the oil company to straighten out its accounts and continue to provide its…
Read More »Capped
Not very expensive and with a yield of 5%, the title of this famous family holding company still has great…
Read More »
Inexpensive, low in debt and with a yield, this world number three in advertising has all the advantages on paper.…
Read More »
A victim of the rotation in favor of more cyclical stocks and demanding valuation levels, the title of this world…
Read More »
Heavily penalized by the health crisis and the consequences of the closure of bars and restaurants, this world agri-food issue…
Read More »
Despite competition from ultra-rapid tests and the arrival of covid vaccines, this world leader in infectious disease diagnostic solutions remains…
Read More »
Close to its historical records, the title of this global player in digital technology and consulting significantly outperforms the market.…
Read More »
Once again penalized by the reconfinement and by the uncertainty surrounding the acquisition of GrandVision, the title of this world…
Read More »Like other health stocks, the title of this world leader in bio-analysis is the subject of significant releases following the…
Read More »
Led by the duo of Xavier Niel and Léon Bressler, a group of shareholders comprising 4.1% of the capital of…
Read More »